Incidence and predictors of invasive candidiasis associated with candidaemia in children

Mycoses

Volumn 54, Issue 2, 2011, Pages 146-153

  Festekjian, Ara ^a   Neely, Michael ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Candidaemia; Invasive; Paediatric; Risk factors

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT;

ARTICLE; CANDIDEMIA; CHILDHOOD DISEASE; CLINICAL EVALUATION; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DATA BASE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; EYE EXAMINATION; HEALTH CARE FACILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENCE; IMMUNOPATHOLOGY; INFANT; INVASIVE CANDIDIASIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MORBIDITY; NONHUMAN; PREDICTOR VARIABLE; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TERTIARY HEALTH CARE; ULTRASOUND;

CANDIDEMIA; CANDIDIASIS, INVASIVE; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79951664007     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2009.01785.x     Document Type: Article

References (33)

1. Edmond M, Wallace S, McClish D, Pfaller M, Jones R, Wenzel R. Nosocomial bloodstream infections in United States hospitals: a three- year analysis. Clin Infect Dis 1999; 29: 239-44.
2. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-17.
3. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the united states: a propensity analysis. Clin Infect Dis 2005; 9: 1232-9.
4. Chiu N, Chung Y, Huang F. Pediatric nosocomial fungal infections. Southeast Asian J Trop Med Public Health 1997; 28: 191-5.
5. Abelson JA, Moore T, Bruckner D, Deville J, Nielsen K. Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a tertiary care institution. Pediatrics 2005; 1: 61-67.
6. Pfaller M, Diekema D, Jones R, Messer S, Hollis R. Trends in antifungal susceptibility of candida spp isolated from pediatric and adult patients with bloodstream infections: SENTRY antimicrobial surveillance program, 1997 to 2000. J Clin Microbiol 2002; 3: 852-6.
7. Raymond J, Aujard Y. Nosocomial infections in pediatric patients: a European, multicenter prospective study. Infect Control Hosp Epidemiol 2000; 4: 260-3.
8. Velasco E, Bigni R. A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia. Eur J Clin Microbiol Infect Dis 2008; 27: 1071-8.
9. Fraser V, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan W. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992; 15: 414-21.
10. Wenzel R. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 1995; 20: 1531-4.
11. Ostrosky-Zeichner L, Sable C, Sobel J et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007; 26: 271-6.
12. Weese-Mayer DE, Fondriest DW, Brouillette RT, Shulman ST. Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J 1987; 6: 190-6.
13. López Sastre JB, Coto Cotallo GD, Fernández Colomer B. Neonatal invasive candidiasis: a prospective multicenter study of 118 cases. Am J Perinatol 2003; 20: 153-63.
14. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia A matched case-control study. Arch Intern Med 1989; 149: 2349-53.
15. Cotten CM, Mcdonald S, Stoll B, Goldberg RN, Poole K, Benjamin DK. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 2006; 118: 717-22.
16. Macdonald L, Baker C, Chenoweth C. Risk factors for candidemia in a children's hospital. Clin Infect Dis 1998; 26: 642-5.
17. Laupland KB, Gregson DB, Church DL, Ross T, Elsayed S. Invasive Candida species infections: a 5year population-based assessment. J Antimicrob Chemother 2005; 56: 532-7.
18. Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 5: 503-35.
19. Zaoutis TE, Greves HM, Lautenbach E, Bilker WB, Coffin SE. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J 2004; 23: 635-41.
20. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008; 9606: 75-84.
21. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 1: 7-14.
22. De Pauw B, Walsh TJ, Donnelly JP et al. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008; 46:1813-21.
23. Stamos JK, Rowley AH. Candidemia in a pediatric population. Clin Infect Dis 1995; 20: 571-5.
24. Chen Y, Chang S, Sun C, Yang L, Hsieh W, Luh K. Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect Control Hosp Epidemiol 1997; 18: 369-75.
25. Pappas PG, Rex JH, Lee J et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 2003; 37: 634-43.
26. Pfaller M, Wenzel R. Impact of the changing epidemiology of fungal infections in the 1990s. Eur J Clin Microbiol Infect Dis 1992; 11: 287-91.
27. Richardson M, Lass-Flörl C. Changing epidemiology of systemic fungal infections. Clin Microbiol Infect. 2008;14 (Suppl. 4) 5-24.
28. Noyola DE, Fernandez M, Moylett EH, Baker CJ. Ophthalmologic, visceral, and cardiac involvement in neonates with candidemia. Clin Infect Dis 2001; 32: 1018-23.
29. Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 1998; 17: 504-8.
30. San Miguel LG, Cobo J, Otheo E et al. Candidemia in pediatric patients with congenital heart disease. Diagn Microbiol Infect Dis 2006; 55: 203-7.
31. Benjamin DK, Poole C, Steinbach WJ, Rowen JL, Walsh TJ. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics 2003; 112 (3 Pt 1): 634-40.
32. Chapman RL, Faix RG. Persistently positive cultures and outcome in invasive neonatal candidiasis. Pediatr Infect Dis J 2000; 19: 822-7.
33. Millar BC, Jugo J, Moore JE. Fungal endocarditis in neonates and children. Pediatr Cardiol 2005; 26: 517-36.